Schedule of Segment Reporting Information |
Net sales and profit by each reportable segment for the three and six months ended June 30, 2025 and 2024 are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | Six Months Ended June 30, 2025 | Dollars in thousands | Codman Specialty Surgical | | Tissue Technologies | | Corporate and Other | | Total | | Codman Specialty Surgical | | Tissue Technologies | | Corporate and Other | | Total | Total revenue, net | $ | 303,958 | | | $ | 111,647 | | | $ | — | | | $ | 415,605 | | | $ | 584,622 | | | $ | 213,636 | | | $ | — | | | $ | 798,258 | | | | | | | | | | | | | | | | | | Cost of goods sold | 102,004 | | | 50,768 | | | 53,501 | | | 206,273 | | | 194,781 | | | 95,830 | | | 103,883 | | | 394,494 | | Research and development | 7,698 | | | 4,334 | | | 14,965 | | | 26,997 | | | 15,643 | | | 8,054 | | | 28,028 | | | 51,725 | | Selling, general & administrative | 69,202 | | | 38,317 | | | 72,371 | | | 179,890 | | | 138,877 | | | 74,805 | | | 147,705 | | | 361,387 | | Intangible asset amortization | — | | | — | | | 3,754 | | | 3,754 | | | — | | | — | | | 7,458 | | | 7,458 | | Goodwill impairment | 388,106 | | | 123,259 | | | — | | | 511,365 | | | 388,106 | | | 123,259 | | | — | | | 511,365 | | Total cost and expenses | 567,010 | | | 216,678 | | | 144,591 | | | 928,279 | | | 737,407 | | | 301,948 | | | 287,074 | | | 1,326,429 | | | | | | | | | | | | | | | | | | Operating income (loss) | $ | (263,052) | | | $ | (105,031) | | | $ | (144,591) | | | (512,674) | | | $ | (152,785) | | | $ | (88,312) | | | $ | (287,074) | | | (528,171) | | Interest income | | | | | | | 4,710 | | | | | | | | | 9,130 | | Interest expense | | | | | | | (21,042) | | | | | | | | | (39,857) | | Other income, net | | | | | | | (1,946) | | | | | | | | | (2,090) | | Loss before income taxes | | | | | | | $ | (530,952) | | | | | | | | | $ | (560,988) | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | | Six Months Ended June 30, 2024 | Dollars in thousands | Codman Specialty Surgical | | Tissue Technologies | | Corporate and Other | | Total | | Codman Specialty Surgical | | Tissue Technologies | | Corporate and Other | | Total | Total revenue, net | $ | 301,761 | | | $ | 116,414 | | | $ | — | | | $ | 418,175 | | | $ | 558,195 | | | $ | 228,852 | | | $ | — | | | $ | 787,047 | | | | | | | | | | | | | | | | | | Cost of goods sold | 92,640 | | | 41,444 | | | 58,174 | | | 192,258 | | | 185,613 | | | 78,983 | | | 89,700 | | | 354,296 | | Research and development | 7,567 | | | 4,451 | | | 17,749 | | | 29,767 | | | 13,332 | | | 9,351 | | | 34,049 | | | 56,732 | | Selling, general & administrative | 37,413 | | | 33,332 | | | 124,727 | | | 195,472 | | | 91,617 | | | 72,665 | | | 196,988 | | | 361,270 | | Intangible asset amortization | — | | | — | | | 3,707 | | | 3,707 | | | — | | | — | | | 13,814 | | | 13,814 | | Goodwill impairment | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | Total cost and expenses | 137,620 | | | 79,227 | | | 204,357 | | | 421,204 | | | 290,562 | | | 160,999 | | | 334,551 | | | 786,112 | | | | | | | | | | | | | | | | | | Operating income (loss) | $ | 164,141 | | | $ | 37,187 | | | $ | (204,357) | | | (3,029) | | | $ | 267,633 | | | $ | 67,853 | | | $ | (334,551) | | | 935 | | Interest income | | | | | | | 5,058 | | | | | | | | | 10,098 | | Interest expense | | | | | | | (18,651) | | | | | | | | | (32,275) | | Other income, net | | | | | | | 1,437 | | | | | | | | | 827 | | Loss before income taxes | | | | | | | $ | (15,185) | | | | | | | | | $ | (20,415) | | | | | | | | | | | | | | | | | |
|